Clinical Trial Update: Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial comparing bevacizumab and ranibizumab for retinal vein occlusion, evaluating effectiveness and costs; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Bevacizumab (bevacizumab)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Retinal Vein Occlusion | Phase 2, Phase 3 | Status: UNKNOWN